dualyx
![dualyx](https://flanders.bio/storage/files/e2c2a429-8c59-4fc6-ba8f-8309096b3e00/company_logo-member-dualyx.jpg)
Technologiepark-Zwijnaarde 94
9052 Gent
BE
dualyx
Foundation date
21/11/2019
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Proteins
- #Other - Industrial Biotechnology
- #Other - Veterinary
- #Pharma - Cell therapy
- #Pharma - Gene therapy
- #Professional Services - IT services
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Musculoskeletal system and connective tissue
- #Respiratory system
- #Skin and subcutaneous tissue
dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need.
Upcoming events
All events-
1109 '24
The Leuven Protein Aggregation Meeting (2nd edition)
Event by: VIB -
1010 '24
-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group
Latest news
More news-
Antonin (Tony) de Fougerolles appointed as new Chair of etherna
Tuesday July 16th 2024
Read more
-
ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust
Tuesday July 16th 2024
Read more
-
Ghent University spin-off Trince wins Nature Spinoff Prize
Monday July 15th 2024
Read more
Jobs
More jobsMore info?
Ellen Telleir
Communication Coordinator